Delivery Order SPE2DB22D2214-SPE2DB25FS6EP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,336.32 to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-tablet supply) on July 31, 2025, with ultimate completion by August 1, 2025. This is a firm fixed price, non-set-aside delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Loestrin 21 1-20 tablets (21-count packages) under a firm fixed-price contract with a ceiling value of $3,580.26. This non-competitive delivery order is expected to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loestrin 21 1-20 Tablet in quantities of 21 units. This is a firm fixed-price delivery order with a ceiling value of $1,790.10 and an ultimate completion date of August 15, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Loestrin 21 1-20 Tablet in quantities of 21 tablets, with a contract ceiling value of $2,983.50 and a firm fixed price structure. The contract is non-set-aside and represents a competitive award for pharmaceutical supply. This delivery order is completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. This competitively awarded, non-set-aside contract carries a ceiling value of $11,276.65 and is classified as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1.81K to AmerisourceBergen Drug Corp for LOESTRIN 21 1-20 tablets (21-count packages) on August 5, 2025, with completion targeted for August 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Loestrin 21 1-20 tablets. The $11,136.05 firm-fixed-price contract has an ultimate completion date of April 18, 2024. AmerisourceBergen Drug Corp, through its Corporate Office Division, is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The company...
- The Defense Logistics Agency awarded a $16,978.49 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4,562,138,127 tablets of Loestrin 21 1.5-30. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the contraceptive tablets to a location in Conshohocken, Pennsylvania by September 13, 2023 under the terms of the order. The parent company, Amerisourcebergen Corporation, will perform the contract through its Amerisourcebergen Corporation...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,123.02 contract is for the supply of Loestrin 21 1-20 tablet 21s, with an ultimate completion date of April 5, 2024. This delivery order is part of a broader indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a $5,301 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 21 packages of Loestrin 21 1.5-30 tablets. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical products to be shipped to a facility in Conshohocken, Pennsylvania by September 6, 2023. Amerisourcebergen will serve as the prime contractor on this order to support the Defense Logistics...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6EPDelivery Order
The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company maintains extensive capabilities in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas. This specific delivery order for Loestrin 21 contraceptive tablets represents one component of the company's comprehensive pharmaceutical support services to federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, delivered through the flexible framework of its prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/18/25 |